Pete A. Williams

5.1k total citations · 1 hit paper
91 papers, 3.1k citations indexed

About

Pete A. Williams is a scholar working on Ophthalmology, Molecular Biology and Neurology. According to data from OpenAlex, Pete A. Williams has authored 91 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Ophthalmology, 41 papers in Molecular Biology and 19 papers in Neurology. Recurrent topics in Pete A. Williams's work include Glaucoma and retinal disorders (42 papers), Retinal Diseases and Treatments (27 papers) and Retinal Development and Disorders (26 papers). Pete A. Williams is often cited by papers focused on Glaucoma and retinal disorders (42 papers), Retinal Diseases and Treatments (27 papers) and Retinal Development and Disorders (26 papers). Pete A. Williams collaborates with scholars based in Sweden, United Kingdom and United States. Pete A. Williams's co-authors include Simon W. M. John, Jeffrey M. Harder, James P. Morgan, Nicole E. Foxworth, James R. Tribble, Gareth R. Howell, Kelly E. Cochran, Marcela Votruba, Wayde N. Martens and Vittorio Porciatti and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Pete A. Williams

80 papers receiving 3.1k citations

Hit Papers

Vitamin B 3 modulates mitochondrial vulnerability and pre... 2017 2026 2020 2023 2017 100 200 300 400

Peers

Pete A. Williams
Imre Lengyel United Kingdom
Dong Ho Park South Korea
Lynda S. Wright United States
Russell C. Scaduto United States
Yoon Kyung Choi South Korea
Rajesh Ambasudhan United States
Pete A. Williams
Citations per year, relative to Pete A. Williams Pete A. Williams (= 1×) peers Raghu R. Krishnamoorthy

Countries citing papers authored by Pete A. Williams

Since Specialization
Citations

This map shows the geographic impact of Pete A. Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pete A. Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pete A. Williams more than expected).

Fields of papers citing papers by Pete A. Williams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pete A. Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pete A. Williams. The network helps show where Pete A. Williams may publish in the future.

Co-authorship network of co-authors of Pete A. Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Pete A. Williams. A scholar is included among the top collaborators of Pete A. Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pete A. Williams. Pete A. Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tribble, James R., Vickie Wong, Kelsey V. Stuart, et al.. (2025). Dysfunctional one-carbon metabolism identifies vitamins B6, B9, B12, and choline as neuroprotective in glaucoma. Cell Reports Medicine. 6(5). 102127–102127.
2.
Brautaset, Rune, Flora Hui, Maria Nilsson, et al.. (2025). Identifying potential key metabolic pathways and biomarkers in glaucoma: a systematic review and meta-analysis. BMJ Open Ophthalmology. 10(1). e002103–e002103. 3 indexed citations
3.
Maioli, Silvia, Ivan Nalvarte, Maria Ankarcrona, et al.. (2025). Bioenergetics and lipid metabolism in Alzheimer's disease: From cell biology to systemic health. Journal of Internal Medicine. 299(1). 20–43.
4.
Brautaset, Rune, et al.. (2024). Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucoma. Molecular Brain. 17(1). 84–84. 4 indexed citations
5.
Tribble, James R., Carmine Varricchio, Romanas Chaleckis, et al.. (2024). NMNAT2 is a druggable target to drive neuronal NAD production. Nature Communications. 15(1). 6256–6256. 14 indexed citations
6.
Hedström, Johan, Maria Nilsson, Martin Engvall, Pete A. Williams, & Abinaya Priya Venkataraman. (2024). Ganglion Cell Complex Thickness and Visual Function in Chronic Leber Hereditary Optic Neuropathy. Investigative Ophthalmology & Visual Science. 65(12). 4–4. 1 indexed citations
7.
Svensson, Jonas E., Daniel E. Thor, Pete A. Williams, et al.. (2024). Evaluating the effect of rapamycin treatment in Alzheimer’s disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocol. BMC Neurology. 24(1). 111–111. 10 indexed citations
8.
Tribble, James R., Mattias Nilsson, Anna Lindqvist, et al.. (2023). Nicotinamide Prevents Retinal Vascular Dropout in a Rat Model of Ocular Hypertension and Supports Ocular Blood Supply in Glaucoma Patients. Investigative Ophthalmology & Visual Science. 64(14). 34–34. 4 indexed citations
9.
Lardner, Emma, et al.. (2023). A serum protein signature at the time of Uveal Melanoma diagnosis predicts long-term patient survival. BMC Cancer. 23(1). 277–277. 8 indexed citations
10.
Williams, Pete A., et al.. (2022). The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature. BMC Cancer. 22(1). 398–398. 15 indexed citations
11.
Hui, Flora, Jessica Tang, Pete A. Williams, et al.. (2020). Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3 ) supplementation: A crossover randomized clinical trial. Clinical and Experimental Ophthalmology. 48(7). 903–914. 134 indexed citations
12.
Hui, Flora, Jessica Tang, Pete A. Williams, et al.. (2020). Improvement in inner retinal function in glaucoma in response to nicotinamide (Vitamin B3) supplementation: a crossover randomized clinical trial. Investigative Ophthalmology & Visual Science. 61(7). 3493–3493. 3 indexed citations
13.
Tribble, James R., Jeffrey M. Harder, Pete A. Williams, & Simon W. M. John. (2020). Ocular hypertension suppresses homeostatic gene expression in optic nerve head microglia of DBA/2 J mice. Molecular Brain. 13(1). 81–81. 36 indexed citations
14.
Bevan, Ryan J., Timothy R. Hughes, Pete A. Williams, et al.. (2020). Retinal ganglion cell degeneration correlates with hippocampal spine loss in experimental Alzheimer’s disease. Acta Neuropathologica Communications. 8(1). 216–216. 30 indexed citations
15.
Tribble, James R., Pete A. Williams, Bruce Caterson, Frank Sengpiel, & James P. Morgan. (2018). Digestion of the glycosaminoglycan extracellular matrix by chondroitinase ABC supports retinal ganglion cell dendritic preservation in a rodent model of experimental glaucoma. Molecular Brain. 11(1). 69–69. 13 indexed citations
16.
Williams, Pete A., Jeffrey M. Harder, Nicole E. Foxworth, et al.. (2017). Vitamin B 3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Science. 355(6326). 756–760. 417 indexed citations breakdown →
17.
Williams, Pete A., N. Marsh‐Armstrong, Gareth R. Howell, et al.. (2017). Neuroinflammation in glaucoma: A new opportunity. Experimental Eye Research. 157. 20–27. 200 indexed citations
18.
Howell, Gareth R., Pete A. Williams, Jeffrey M. Harder, et al.. (2016). The yin and yang of the complement cascade in glaucoma – the importance of timing and location. Investigative Ophthalmology & Visual Science. 57(12). 1 indexed citations
19.
Williams, Pete A., James P. Morgan, & Marcela Votruba. (2010). Mouse models of dominant optic atrophy: What do they tell us about the pathophysiology of visual loss?. Vision Research. 51(2). 229–234. 25 indexed citations
20.
Thomas, D.R., et al.. (1987). Thyroid status in senile dementia of the Alzheimer type (SDAT). Acta Psychiatrica Scandinavica. 76(2). 158–163. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026